Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Stillitano

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Stem Cell Research|March 12, 2026
Generation and characterization of induced pluripotent stem cell (iPSC) lines from two symptomatic carriers of pathogenic TNNI3 variants and two non-carrier relativesPaulo Starčević, Michele F Buono, Femke Pol, et al.
Journal of Cardiovascular Electrophysiology|July 23, 2013
Chronic atrial fibrillation alters the functional properties of If in the human atriumFrancesca Stillitano, Giuseppe Lonardo, Gabriele Giunti, et al.
Circulation. Heart Failure|September 24, 2025
Unraveling the Pathophysiological Mechanisms of Phospholamban R14del Cardiomyopathy: A Comprehensive OverviewRenee G C Maas, Luuk Kerckhaert, Judy A Broersma, et al.
European Heart Journal|July 25, 2016
Genomic correction of familial cardiomyopathy in human engineered cardiac tissuesFrancesca Stillitano, Irene C Turnbull, Ioannis Karakikes, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 21, 2010
Prenatal exposure to carbon monoxide delays postnatal cardiac maturationLaura Sartiani, Francesca Stillitano, Cristina Luceri, et al.
Stem Cell Research|November 2, 2025
Generation and characterization of human induced pluripotent stem cell (iPSC) lines from two asymptomatic Greek carriers of the Phospholamban (PLN)-R14del pathogenic variant and a non-carrier relativeKaren R Gaar-Humphreys, Valentina Balducci, Femke Pol, et al.
Stem Cell Research|March 5, 2022
Generation of human induced pluripotent stem cell (iPSC) lines derived from five patients carrying the pathogenic phospholamban-R14del (PLN-R14del) variant and three non-carrier family membersNishka Mittal, Jaydev Dave, Magdalena Harakalova, et al.
Stem Cell Research|September 25, 2023
Generation and characterization of novel human induced pluripotent stem cell (iPSC) lines originating from five asymptomatic individuals carrying the PLN-R14del pathogenic variant and a non-carrier relativeValentina Balducci, Francesco Scardigli, Magdalena Harakalova, et al.
Stem Cell Research & Therapy|December 6, 2019
Adult human cardiac stem cell supplementation effectively increases contractile function and maturation in human engineered cardiac tissuesJack F Murphy, Joshua Mayourian, Francesca Stillitano, et al.
Metabolism: Clinical and Experimental|November 14, 2022
Isoform changes of action potential regulators in the ventricles of arrhythmogenic phospholamban-R14del humanized mouse heartsMalgorzata E Rogalska, Elizabeth Vafiadaki, Zoi Erpapazoglou, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Stem Cell Research|March 12, 2026
Generation and characterization of induced pluripotent stem cell (iPSC) lines from two symptomatic carriers of pathogenic TNNI3 variants and two non-carrier relativesPaulo Starčević, Michele F Buono, Femke Pol, et al.
Journal of Cardiovascular Electrophysiology|July 23, 2013
Chronic atrial fibrillation alters the functional properties of If in the human atriumFrancesca Stillitano, Giuseppe Lonardo, Gabriele Giunti, et al.
Circulation. Heart Failure|September 24, 2025
Unraveling the Pathophysiological Mechanisms of Phospholamban R14del Cardiomyopathy: A Comprehensive OverviewRenee G C Maas, Luuk Kerckhaert, Judy A Broersma, et al.
European Heart Journal|July 25, 2016
Genomic correction of familial cardiomyopathy in human engineered cardiac tissuesFrancesca Stillitano, Irene C Turnbull, Ioannis Karakikes, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 21, 2010
Prenatal exposure to carbon monoxide delays postnatal cardiac maturationLaura Sartiani, Francesca Stillitano, Cristina Luceri, et al.
Stem Cell Research|November 2, 2025
Generation and characterization of human induced pluripotent stem cell (iPSC) lines from two asymptomatic Greek carriers of the Phospholamban (PLN)-R14del pathogenic variant and a non-carrier relativeKaren R Gaar-Humphreys, Valentina Balducci, Femke Pol, et al.
Stem Cell Research|March 5, 2022
Generation of human induced pluripotent stem cell (iPSC) lines derived from five patients carrying the pathogenic phospholamban-R14del (PLN-R14del) variant and three non-carrier family membersNishka Mittal, Jaydev Dave, Magdalena Harakalova, et al.
Stem Cell Research|September 25, 2023
Generation and characterization of novel human induced pluripotent stem cell (iPSC) lines originating from five asymptomatic individuals carrying the PLN-R14del pathogenic variant and a non-carrier relativeValentina Balducci, Francesco Scardigli, Magdalena Harakalova, et al.
Stem Cell Research & Therapy|December 6, 2019
Adult human cardiac stem cell supplementation effectively increases contractile function and maturation in human engineered cardiac tissuesJack F Murphy, Joshua Mayourian, Francesca Stillitano, et al.
Metabolism: Clinical and Experimental|November 14, 2022
Isoform changes of action potential regulators in the ventricles of arrhythmogenic phospholamban-R14del humanized mouse heartsMalgorzata E Rogalska, Elizabeth Vafiadaki, Zoi Erpapazoglou, et al.
Pageof 5